Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

UnitedHealth’s Physician Network Strategy Drives Billions in Additional Medicare Revenue

by Team Lumida
December 30, 2024
in Health and Longevity
Reading Time: 2 mins read
A A
0
yellow medication pill on persons hand

Photo by Alexander Grey on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com
• UnitedHealth patients showed 55% increase in sickness scores after switching to Medicare Advantage
• Company’s physician network generated $4.6 billion in additional Medicare payments
• Doctors report being presented with pre-populated diagnosis checklists for Medicare Advantage patients
• Strategy represents significant departure from traditional insurance-provider relationship

What Happened?

A Wall Street Journal analysis has revealed that UnitedHealth Group’s strategy of employing physicians and implementing diagnosis suggestion systems has resulted in substantially higher Medicare Advantage payments. The company’s patients showed a 55% increase in sickness scores upon entering their Medicare Advantage plans, compared to just 7% for traditional Medicare patients. This practice, implemented through a network of approximately 10,000 employed physicians, involves presenting doctors with pre-populated diagnosis checklists specifically for Medicare Advantage patients.

Why It Matters?

This development highlights the evolving landscape of healthcare business models and their financial implications. UnitedHealth’s approach represents a significant shift in how insurers interact with healthcare delivery, potentially setting new industry standards. The strategy’s success in generating additional revenue ($4.6 billion in extra Medicare payments) demonstrates the financial advantages of vertical integration in healthcare, while also raising questions about the Medicare Advantage payment system’s effectiveness and oversight.

What’s Next?

Industry observers should watch for potential regulatory responses to these practices, as they may trigger increased scrutiny of Medicare Advantage payment systems. Other insurers might follow UnitedHealth’s model of physician employment and diagnosis management, potentially reshaping the healthcare industry structure. Investors should monitor potential policy changes that could affect profitability in the Medicare Advantage space, as well as competitors’ strategies to either emulate or differentiate from UnitedHealth’s approach. The sustainability of these practices and their impact on healthcare costs will likely become key topics in healthcare policy discussions.

Previous Post

Oil Prices Edge Lower in Thin Holiday Trading Despite Strong US Inventory Data

Next Post

US Credit Card Defaults Surge to Post-2008 Highs, Signaling Consumer Stress

Recommended For You

Most “Longevity Drugs” Don’t Work the Way You Think

by Team Lumida
1 hour ago
diagram

Key takeaways Powered by lumidawealth.com Most longevity drugs improve markers, not actual lifespan. Human evidence is weak for many popular compounds. Drug benefits are context-dependent — not universal. Lifestyle...

Read more

Walking After Meals Is a Simple Hack for Blood Sugar Control

by Team Lumida
1 day ago
woman walking on pathway during daytime

Key takeaways Powered by lumidawealth.com Just 10–15 minutes of walking after meals can lower post-meal blood sugar spikes. Light activity helps muscles absorb glucose without needing as much insulin....

Read more

Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

by Team Lumida
1 day ago
Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

Key takeaways Powered by lumidawealth.com India is about to become a major generic GLP-1 market, with multiple drugmakers preparing cheaper semaglutide launches after patent expiry. Prices could fall by...

Read more

Vinegar Before Meals May Help Control Blood Sugar

by Team Lumida
4 days ago
Several small glass bottles with orange liquid

Key takeaways Powered by lumidawealth.com 1–2 tablespoons of vinegar before meals can lower post-meal glucose spikes. Acetic acid slows carbohydrate digestion and glucose absorption. Studies show vinegar can improve...

Read more

Avocados Are the Metabolic Health Hack Most Diets Miss

by Team Lumida
5 days ago
sliced green avocado fruit

Key takeaways Powered by lumidawealth.com Avocados are rich in monounsaturated fats that support heart and metabolic health. High fiber content helps regulate blood sugar and appetite. They provide potassium,...

Read more

Fiber Before Meals Is the Natural GLP-1 Hack

by Team Lumida
6 days ago
Fiber Before Meals Is the Natural GLP-1 Hack

Key takeaways Powered by lumidawealth.com Fiber stimulates GLP-1, the same hormone targeted by popular weight-loss drugs. Eating fiber before meals reduces appetite and slows glucose spikes. It improves gut...

Read more

Walking After Meals Is the Longevity Hack

by Team Lumida
1 week ago
shallow focus photography of person walking on road between grass

Key takeaways Powered by lumidawealth.com A 10–15 minute walk after meals significantly lowers blood sugar spikes. Post-meal walking improves insulin sensitivity and metabolic health. Regular light movement after eating...

Read more

Fiber Is the Longevity Hack Most Diets Still Miss

by Team Lumida
1 week ago
green leaves on blue plastic bowl

Key takeaways Powered by lumidawealth.com Higher fiber intake is associated with lower mortality and chronic disease risk. Fiber improves gut microbiome health, which affects metabolism, immunity, and inflammation. Most...

Read more

Mobile Screens Are the Modern Health Risk Hiding in Plain Sight

by Team Lumida
2 weeks ago
person holding blue and white box

Key takeaways Powered by lumidawealth.com High mobile screen time is linked to poorer sleep quality, largely due to blue light exposure and late-night device use. Digital overuse contributes to...

Read more

Protein Timing Is the Longevity Multiplier

by Team Lumida
2 weeks ago
a container of protein powder next to a spoon

Key takeaways Most adults under-consume protein at breakfast and overconsume it at dinner. Muscle protein synthesis is optimized when ~25–40g of protein is consumed per meal. Even distribution...

Read more
Next Post
US Credit Card Defaults Surge to Post-2008 Highs, Signaling Consumer Stress

US Credit Card Defaults Surge to Post-2008 Highs, Signaling Consumer Stress

100 us dollar bill

Vietnam's Dong Hits Historic Low as Dollar Strengthens on Trump Victory

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

apple logo on blue surface

Apple Earnings Highlights: Strong Services Growth and AI Innovation Drive Record Q3 Results

August 2, 2024
Gavin Newsom: China’s Preferred U.S. Presidential Candidate?

Gavin Newsom: China’s Preferred U.S. Presidential Candidate?

July 2, 2024
Broadcom Inc. Q3 2024 Earnings Highlights: Significant revenue growth and strategic advancements in AI

Broadcom Inc. Q3 2024 Earnings Highlights: Significant revenue growth and strategic advancements in AI

September 6, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018